Celecoxib inhibits Na+ currents in rat dorsal root ganglion neurons

Brain Research

Volumn 1148, Issue 1, 2007, Pages 53-61

  Park, Soon Yong ^a   Kim, Tae Hoon ^a   Kim, Hong Im ^a   Shin, Yong Kyoo ^a   Lee, Chung Soo ^a   Park, Mijung ^b   Song, Jin Ho ^a  

^a Chung Ang University   (South Korea)

^b Seoul National University of Science and Technology   (South Korea)

Author keywords

Analgesia; Celecoxib; Dorsal root ganglion; Na+ current; Tetrodotoxin resistant; Tetrodotoxin sensitive

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; SODIUM ION; TETRODOTOXIN; VOLTAGE GATED SODIUM CHANNEL;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DISSOCIATION CONSTANT; DOSE RESPONSE; DRUG BINDING; DRUG EFFECT; ENZYME INHIBITION; EVOKED RESPONSE; HYPERPOLARIZATION; NERVE EXCITABILITY; NONHUMAN; PAIN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SODIUM CURRENT; SPINAL GANGLION; STEADY STATE;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; GANGLIA, SPINAL; ION CHANNEL GATING; MEMBRANE POTENTIALS; NEURONS, AFFERENT; NOCICEPTORS; PAIN; PATCH-CLAMP TECHNIQUES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; SULFONAMIDES; TETRODOTOXIN;

RATTUS;

EID: 34247175426     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.02.023     Document Type: Article

References (36)

1. Akada Y., Ogawa S., Amano K., Fukudome Y., Yamasaki F., Itoh M., and Yamamoto I. Potent analgesic effects of a putative sodium channel blocker M58373 on formalin-induced and neuropathic pain in rats. Eur. J. Pharmacol. 536 (2006) 248-255
2. Akopian A.N., Sivilotti L., and Wood J.N. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379 (1996) 257-262
3. Akopian A.N., Souslova V., England S., Okuse K., Ogata N., Ure J., Smith A., Kerr B.J., McMahon S.B., Boyce S., Hill R., Stanfa L.C., Dickenson A.H., and Wood J.N. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat. Neurosci. 2 (1999) 541-548
4. Amir R., Argoff C.E., Bennett G.J., Cummins T.R., Durieux M.E., Gerner P., Gold M.S., Porreca F., and Strichartz G.R. The role of sodium channels in chronic inflammatory and neuropathic pain. J. Pain 7 (2006) S1-S29
5. + channels confer invasive properties on human prostate cancer cells. Pflugers Arch. 447 (2004) 908-914
6. Black J.A., Liu S., Tanaka M., Cummins T.R., and Waxman S.G. Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain. Pain 108 (2004) 237-247
7. Chun K.S., and Surh Y.J. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 68 (2004) 1089-1100
8. Cox J.J., Reimann F., Nicholas A.K., Thornton G., Roberts E., Springell K., Karbani G., Jafri H., Mannan J., Raashid Y., Al-Gazali L., Hamamy H., Valente E.M., Gorman S., Williams R., McHale D.P., Wood J.N., Gribble F.M., and Woods C.G. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444 (2006) 894-898
9. Craner M.J., Damarjian T.G., Liu S., Hains B.C., Lo A.C., Black J.A., Newcombe J., Cuzner M.L., and Waxman S.G. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia 49 (2005) 220-229
10. Cummins T.R., Dib-Hajj S.D., Black J.A., Akopian A.N., Wood J.N., and Waxman S.G. A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons. J. Neurosci. 19 (1999) RC43
11. Davies N.M., McLachlan A.J., Day R.O., and Williams K.M. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin. Pharmacokinet. 38 (2000) 225-242
12. Deeks J.J., Smith L.A., and Bradley M.D. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. BMJ 325 (2002) 619-626
13. Dib-Hajj S.D., Tyrrell L., Black J.A., and Waxman S.G. NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 8963-8968
14. + channel α subunit protein. J. Physiol. 546 (2003) 565-576
15. Drachman D.B., Frank K., Dykes-Hoberg M., Teismann P., Almer G., Przedborski S., and Rothstein J.D. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 52 (2002) 771-778
16. Ferrante F.M., Paggioli J., Cherukuri S., and Arthur G.R. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesth. Analg. 82 (1996) 91-97
17. + current in nociceptors. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 1108-1112
18. v1.8 in uninjured axons enables neuropathic pain. J. Neurosci. 23 (2003) 158-166
19. Goldin A.L. Resurgence of sodium channel research. Annu. Rev. Physiol. 63 (2001) 871-894
20. Ito S., Okuda-Ashitaka E., and Minami T. Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci. Res. 41 (2001) 299-332
21. Kretschmer T., Happel L.T., England J.D., Nguyen D.H., Tiel R.L., Beuerman R.W., and Kline D.G. Accumulation of PN1 and PN3 sodium channels in painful human neuroma-evidence from immunocytochemistry. Acta Neurochir. 144 (2002) 803-810
22. V1.8. Pain 95 (2002) 143-152
23. Lee H.M., Kim H.I., Shin Y.K., Lee C.S., Park M., and Song J.H. Diclofenac inhibition of sodium currents in rat dorsal root ganglion neurons. Brain Res. 992 (2003) 120-127
24. Lo A.C., Saab C.Y., Black J.A., and Waxman S.G. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J. Neurophysiol. 90 (2003) 3566-3571
25. Lynch III J.J., Wade C.L., Zhong C.M., Mikusa J.P., and Honore P. Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model. Pain 110 (2004) 56-63
26. Miyamoto K., Miyake S., Mizuno M., Oka N., Kusunoki S., and Yamamura T. Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway. Brain 129 (2006) 1984-1992
27. Obrenovitch T.P. Amyotrophic lateral sclerosis, excitotoxicity and riluzole. Trends Pharmacol. Sci. 19 (1998) 9-11
28. + channel expression in vitro. J. Membr. Biol. 204 (2005) 67-75
29. + channels in C-type DRG neurons by S-nitrosylation. J. Neurophysiol. 87 (2002) 761-775
30. Rodrigues-Filho R., Campos M.M., Ferreira J., Santos A.R.S., Bertelli J.A., and Calixto J.B. Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain. Brain Res. 1018 (2004) 159-170
31. Roy M.L., and Narahashi T. Differential properties of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in rat dorsal root ganglion neurons. J. Neurosci. 12 (1992) 2104-2111
32. Scholz A., and Vogel W. Tetrodotoxin-resistant action potentials in dorsal root ganglion neurons are blocked by local anesthetics. Pain 89 (2000) 47-52
33. Veiga A.P.C., Duarte I.D.G., Ávila M.N., da Motta P.G., Tatsuo M.A.K.F., and Francischi J.N. Prevention by celecoxib of secondary hyperalgesia induced by formalin in rats. Life Sci. 75 (2004) 2807-2817
34. Waxman S.G., Dib-Hajj S., Cummins T.R., and Black J.A. Sodium channels and pain. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7635-7639
35. Wood J.N., Boorman J.P., Okuse K., and Baker M.D. Voltage-gated sodium channels and pain pathways. J. Neurobiol. 61 (2004) 55-71
36. Yang Y., Wang Y., Li S., Xu Z., Li H., Ma L., Fan J., Bu D., Liu B., Fan Z., Wu G., Jin J., Ding B., Zhu X., and Shen Y. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J. Med. Genet. 41 (2004) 171-174